Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia

Acute myeloid leukemia (AML) is the most lethal leukemia with an extremely poor prognosis and high relapse rates. In leukemogenesis, adhesion abnormalities can readily guide an imbalance between hematopoietic progenitor cells and bone marrow stromal cells, altering the normal hematopoietic bone marr...

Full description

Bibliographic Details
Main Authors: Sameh A. Mohammed, Yasuhiro Kimura, Yuhki Toku, Yang Ju
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Biomaterials and Biosystems
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666534422000071
_version_ 1828349434715439104
author Sameh A. Mohammed
Yasuhiro Kimura
Yuhki Toku
Yang Ju
author_facet Sameh A. Mohammed
Yasuhiro Kimura
Yuhki Toku
Yang Ju
author_sort Sameh A. Mohammed
collection DOAJ
description Acute myeloid leukemia (AML) is the most lethal leukemia with an extremely poor prognosis and high relapse rates. In leukemogenesis, adhesion abnormalities can readily guide an imbalance between hematopoietic progenitor cells and bone marrow stromal cells, altering the normal hematopoietic bone marrow microenvironment into leukemic transformation that enhances leukemic proliferation. Here, we have firstly studied the PLEKHA7 expression in leukemic cells to assess their growth capability affected by the restoration of PLEKHA7 in the cells. The efficacy of PLEKHA7-loaded cRGD-mediated PEGylated cationic lipid nanoparticles for efficient PLEKHA7 delivery in leukemic cells as well as the effect of PLEKHA7 on the regulated induction of AML behavior and growth alterations were investigated. PLEKHA7 re-expression diminished colony-forming ability and reinforced the incidence of growth retardation without apoptosis in AML cell lines. PLEKHA7 regulated the restoration of cell surface adhesion and integrity during normal homeostasis. Our findings revealed that PLEKHA7 functions as a behavior and growth modulator in AML. To our knowledge, the role of PLEKHA7 in AML had not been studied previously and our data could be exploited for further mechanistic studies and insights into altering human AML behavior and growth.
first_indexed 2024-04-14T01:09:29Z
format Article
id doaj.art-8fa631ca22024aa8be020520c010c75c
institution Directory Open Access Journal
issn 2666-5344
language English
last_indexed 2024-04-14T01:09:29Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Biomaterials and Biosystems
spelling doaj.art-8fa631ca22024aa8be020520c010c75c2022-12-22T02:21:08ZengElsevierBiomaterials and Biosystems2666-53442022-06-016100045Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemiaSameh A. Mohammed0Yasuhiro Kimura1Yuhki Toku2Yang Ju3Department of Micro-Nano Mechanical Science and Engineering, Graduate School of Engineering, Nagoya University; Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, EgyptDepartment of Micro-Nano Mechanical Science and Engineering, Graduate School of Engineering, Nagoya University; Furo-cho, Chikusa-ku, Nagoya, 464-8603, JapanDepartment of Micro-Nano Mechanical Science and Engineering, Graduate School of Engineering, Nagoya University; Furo-cho, Chikusa-ku, Nagoya, 464-8603, JapanDepartment of Micro-Nano Mechanical Science and Engineering, Graduate School of Engineering, Nagoya University; Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan; Corresponding author at: Department of Mechanical Science and Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.Acute myeloid leukemia (AML) is the most lethal leukemia with an extremely poor prognosis and high relapse rates. In leukemogenesis, adhesion abnormalities can readily guide an imbalance between hematopoietic progenitor cells and bone marrow stromal cells, altering the normal hematopoietic bone marrow microenvironment into leukemic transformation that enhances leukemic proliferation. Here, we have firstly studied the PLEKHA7 expression in leukemic cells to assess their growth capability affected by the restoration of PLEKHA7 in the cells. The efficacy of PLEKHA7-loaded cRGD-mediated PEGylated cationic lipid nanoparticles for efficient PLEKHA7 delivery in leukemic cells as well as the effect of PLEKHA7 on the regulated induction of AML behavior and growth alterations were investigated. PLEKHA7 re-expression diminished colony-forming ability and reinforced the incidence of growth retardation without apoptosis in AML cell lines. PLEKHA7 regulated the restoration of cell surface adhesion and integrity during normal homeostasis. Our findings revealed that PLEKHA7 functions as a behavior and growth modulator in AML. To our knowledge, the role of PLEKHA7 in AML had not been studied previously and our data could be exploited for further mechanistic studies and insights into altering human AML behavior and growth.http://www.sciencedirect.com/science/article/pii/S2666534422000071Acute myeloid leukemiaPLEKHA7NanoparticlesModulatorNormal homeostasis
spellingShingle Sameh A. Mohammed
Yasuhiro Kimura
Yuhki Toku
Yang Ju
Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
Biomaterials and Biosystems
Acute myeloid leukemia
PLEKHA7
Nanoparticles
Modulator
Normal homeostasis
title Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
title_full Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
title_fullStr Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
title_full_unstemmed Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
title_short Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
title_sort bioengineered plekha7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
topic Acute myeloid leukemia
PLEKHA7
Nanoparticles
Modulator
Normal homeostasis
url http://www.sciencedirect.com/science/article/pii/S2666534422000071
work_keys_str_mv AT samehamohammed bioengineeredplekha7nanodeliveryregularlyinducesbehavioralterationandgrowthretardationofacutemyeloidleukemia
AT yasuhirokimura bioengineeredplekha7nanodeliveryregularlyinducesbehavioralterationandgrowthretardationofacutemyeloidleukemia
AT yuhkitoku bioengineeredplekha7nanodeliveryregularlyinducesbehavioralterationandgrowthretardationofacutemyeloidleukemia
AT yangju bioengineeredplekha7nanodeliveryregularlyinducesbehavioralterationandgrowthretardationofacutemyeloidleukemia